Content by OSE Immunotherapeutics

|2 min read

Positive Phase 3 Data Demonstrate NSCLC Vaccine’s Efficacy

Tedopi® safely improved overall survival and quality of life in patients with hard-to-treat non-small cell lung cancer
Page 1 of 1